Stavroula I.
- Country
- Greece
- Department
- Pediatric Intensive Care
Research Overview
- C3601008 - A PHASE 2A MULTICENTER, OBSERVER-BLINDED, RANDOMIZED 2 ARM STUDY TO INVESTIGATE PHARMACOKINETICS, SAFETY, TOLERABILITY AND EFFICACY OF INTRAVENOUS AZTREONAM-AVIBACTAM ± METRONIDAZOLE COMPARED TO BEST AVAILABLE THERAPY (BAT) IN PEDIATRIC PARTICIPANTS 9 MONTHS TO LESS THAN 18 YEARS OF AGE WITH SERIOUS GRAM-NEGATIVE BACTERIAL INFECTIONS INCLUDING COMPLICATED INTRA-ABDOMINAL INFECTION
- Evaluation of Pharmacokinetics, Safety, and Tolerability of Aztreonam-Avibactam ± Metronidazole in Neonates and Infants with Gram-Negative Infections
Data & Insights
Has run more than one trial at 6 of 26 partner sites.
Specializations
Pediatric Infectious Diseases
The investigator specializes in treating serious gram-negative bacterial infections in children, with particular focus on both pediatric and neonatal populations, ranging from newborns to adolescents under 18 years.
- Neonatal infections
- Pediatric bacterial diseases
- Complex bacterial pathologies
Critical Care Infections
Expertise extends to managing severe hospital-acquired conditions, including ventilator-associated pneumonia and hospital-acquired pneumonia in young patients. The investigator addresses blood stream infections and sepsis in critical care settings.
- Hospital-acquired infections
- Systemic infections
- Critical care therapeutics
Complex Bacterial Infections
Focuses on treating complicated urinary tract infections and complicated intra-abdominal infections in pediatric populations. The investigator has particular interest in innovative therapeutic approaches for resistant bacterial strains.
- Urological infections
- Abdominal infections
- Antimicrobial therapy
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.